Your browser doesn't support javascript.
loading
Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes.
Zhao, Qi; Wang, Xijie; Wang, Shuyan; Song, Zheng; Wang, Jiaxian; Ma, Jing.
Affiliation
  • Zhao Q; China State Institutes of Pharmaceutical Industry National Shanghai Center for New Drug Safety Evaluation and Research, Shanghai, China.
  • Wang X; China State Institutes of Pharmaceutical Industry National Shanghai Center for New Drug Safety Evaluation and Research, Shanghai, China.
  • Wang S; China State Institutes of Pharmaceutical Industry National Shanghai Center for New Drug Safety Evaluation and Research, Shanghai, China.
  • Song Z; China State Institutes of Pharmaceutical Industry National Shanghai Center for New Drug Safety Evaluation and Research, Shanghai, China.
  • Wang J; Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China.
  • Ma J; China State Institutes of Pharmaceutical Industry National Shanghai Center for New Drug Safety Evaluation and Research, Shanghai, China. forapplew@163.com.
Stem Cell Res Ther ; 8(1): 54, 2017 03 09.
Article in En | MEDLINE | ID: mdl-28279214
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myocytes, Cardiac / Induced Pluripotent Stem Cells / Cardiotoxicity / Human Embryonic Stem Cells Limits: Humans Language: En Journal: Stem Cell Res Ther Year: 2017 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myocytes, Cardiac / Induced Pluripotent Stem Cells / Cardiotoxicity / Human Embryonic Stem Cells Limits: Humans Language: En Journal: Stem Cell Res Ther Year: 2017 Document type: Article Affiliation country: China